Dorota Katarzyna Pazdyk Goplen
Stilling
Førsteamanuensis
Tilhørighet
Publikasjoner
Vitenskapelig artikkel
- Ueland, Hans Olav; Jensen, Svein Arthur Hønsi; Rødahl, Eyvind et al. (2026). Outcomes in Norwegian Cohort with Malignant Orbital Tumours. (ekstern lenke)
- Joensuu, Heikki; Reichardt, Annette; Eriksson, Mikael et al. (2024). Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. (ekstern lenke)
- Yndestad, Synnøve; Haugland, Hans Kristian; Goplen, Dorota Katarzyna Pazdyk et al. (2024). Germline variants in patients diagnosed with pediatric soft tissue sarcoma. (ekstern lenke)
- Blakstad, Hanne Kristin; Brekke, Jorunn; Rahman, Mohummad Aminur et al. (2023). Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions. (ekstern lenke)
- Hannisdal, Marianne Hjellvik; Goplen, Dorota; Alam, Saruar et al. (2023). Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI. (ekstern lenke)
- Alam, Saruar; Halandur, Bharath; Mana, PierGianLuca Porta et al. (2022). Brain Tumor Segmentation from Multiparametric MRI Using a Multi-encoder U-Net Architecture. (ekstern lenke)
- Rahman, Mohummad Aminur; Engelsen, Agnete; Sarowar, Shahin et al. (2022). Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway. (ekstern lenke)
- Eriksson, Mikael; Reichardt, Peter; Joensuu, H. et al. (2021). Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST). (ekstern lenke)
- Rahman, Mohummad Aminur; Brekke, Jorunn; Arnesen, Victoria Smith et al. (2020). Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study. (ekstern lenke)
- Rahman, Mohummad Aminur; Navarro, Andrea Gras; Brekke, Jorunn et al. (2019). Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival. (ekstern lenke)
- Hall, Kirsten Sundby; Bruland, Øyvind; Bjerkehagen, Bodil et al. (2018). Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors—A Scandinavian Sarcoma Group study (SSG XX). (ekstern lenke)
- Netland, Inger Anne; Førde-Tislevoll, Hilde Elise; Sleire, Linda et al. (2016). Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats. (ekstern lenke)
- Netland, Inger Anne; Førde-Tislevoll, Hilde Elise; Sleire, Linda et al. (2016). Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models. (ekstern lenke)
- Goplen, Dorota; Bougnaud, Sébastien; Rajcevic, Uros et al. (2010). alpha B-Crystallin Is Elevated in Highly Infiltrative Apoptosis-Resistant Glioblastoma Cells. (ekstern lenke)
- Christensen, Karina; Aaberg-Jessen, Charlotte; Andersen, Claus et al. (2010). Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium. (ekstern lenke)
- Huszthy, Peter Csaba; Immervoll, Heike; Wang, Jian et al. (2010). Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment. (ekstern lenke)
- Huszthy, Peter Csaba; Goplen, Dorota; Thorsen, Frits Alan et al. (2008). Oncolytic herpes simplex virus type-1 therapy in a highly infiltrative animal model of human glioblastoma. (ekstern lenke)
- Piepoli, Tiziana; Jakupoglu, Cemile; Gu, Wenli et al. (2006). Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1. (ekstern lenke)
- Goplen, Dorota; Wang, Jian; Enger, Per Øyvind et al. (2006). Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. (ekstern lenke)
Vitenskapelig foredrag
- Bragstad, Sidsel Marit; Tveiten, Øystein Vesterli; BEHBAHANI, MAZIAR et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
- Bragstad, Sidsel Marit; Tveiten, Øystein Vesterli; BEHBAHANI, MAZIAR et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
- Skeie, Bente Sandvei; Bragstad, Sidsel Marit; Goplen, Dorota Katarzyna Pazdyk et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
- Enger, Per Øyvind; Bragstad, Sidsel Marit; Heggdal, Jan Ingemann et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
- Enger, Per Øyvind; Bragstad, Sidsel Marit; Tveiten, Øystein Vesterli et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
Sammendrag/Abstract
- Førde, Hilde Elise Sundøy; Netland, Inger Anne; Sleire, Linda et al. (2013). COMBINED ANTI-ANGIOGENIC AND ANTI-INVASIVE TREATMENT OF ORTHOTOPICALLY ENGRAFTED HUMAN GBM XENOGRAFTS. (ekstern lenke)
- Goplen, Dorota; Wang, Jian; Tysnes, Berit Bølge et al. (2005). Bacitracin inhibits glioma cell migration and invasion in vitro. (ekstern lenke)